Eli Lilly (LLY) Receivables - Net (2009 - 2026)
Eli Lilly's Receivables - Net came in at $20.08 billion for Q2 2026, up 41.7% from $14.17 billion a year earlier and up 9.0% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly's Receivables - Net was $17.76 billion, up 61.4% from FY2024.
- Receivables - Net has increased in each of the last six years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $11.01 billion in FY2024 (+21.1%), $9.09 billion in FY2023 (+31.8%), $6.9 billion in FY2022 (+3.3%) and $6.67 billion in FY2021 (+13.6%).
- The Q2 2026 figure represents the highest quarterly Receivables - Net in data going back to Q2 2009.
- Year-over-year, Receivables - Net has increased for 26 consecutive quarters, with growth averaging 42.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Receivables - Net ranged from 3.3% (Q4 2022) to 61.4% (Q4 2025).
- Business Quant data shows LLY's Receivables - Net at $18.43 billion (Q1 2026), $17.76 billion (Q4 2025) and $16.11 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.08 Bn |
| Mar 31, 2026 | 18.43 Bn |
| Dec 31, 2025 | 17.76 Bn |
| Sep 30, 2025 | 16.11 Bn |
| Jun 30, 2025 | 14.17 Bn |
| Mar 31, 2025 | 12.04 Bn |
| Dec 31, 2024 | 11.01 Bn |
| Sep 30, 2024 | 10.29 Bn |
| Jun 30, 2024 | 11.03 Bn |
| Mar 31, 2024 | 7.89 Bn |
| Dec 31, 2023 | 9.09 Bn |
| Sep 30, 2023 | 8.17 Bn |
| Jun 30, 2023 | 7.52 Bn |
| Mar 31, 2023 | 7.53 Bn |
| Dec 31, 2022 | 6.90 Bn |
| Sep 30, 2022 | 6.72 Bn |
| Jun 30, 2022 | 6.36 Bn |
| Mar 31, 2022 | 6.32 Bn |
| Dec 31, 2021 | 6.67 Bn |
| Sep 30, 2021 | 5.91 Bn |
API Access
Eli Lilly Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();